Shandong Boan Biotechnology Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005RV4
HKD
6.98
-5.3 (-43.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
The United Laboratories International Holdings Ltd.
Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Grand Pharmaceutical Group Ltd.
Simcere Pharmaceutical Group Ltd.
Luye Pharma Group Ltd.
SSY Group Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd.
Shandong Boan Biotechnology Co., Ltd.
InnoCare Pharma Ltd.
Keymed Biosciences, Inc.

Why is Shandong Boan Biotechnology Co., Ltd. ?

1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
  • Poor long term growth as Operating profit has grown by an annual rate 4.66% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -20.86%, its profits have risen by 87.2% ; the PEG ratio of the company is 0.4
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -20.86% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shandong Boan Biotechnology Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Shandong Boan Biotechnology Co., Ltd.
-100.0%
-0.25
97.46%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.07%
EBIT Growth (5y)
4.66%
EBIT to Interest (avg)
-0.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
45.84
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
4.94
EV to EBIT
-180.21
EV to EBITDA
-184.56
EV to Capital Employed
3.93
EV to Sales
22.47
PEG Ratio
0.38
Dividend Yield
NA
ROCE (Latest)
-2.18%
ROE (Latest)
24.31%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET SALES(Q)

Highest at HKD 422.58 MM

OPERATING PROFIT(Q)

Highest at HKD 88.47 MM

OPERATING PROFIT MARGIN(Q)

Highest at 20.93 %

RAW MATERIAL COST(Y)

Fallen by -18.9% (YoY

CASH AND EQV(HY)

Highest at HKD 736.17 MM

-6What is not working for the Company
INTEREST(HY)

At HKD 20.98 MM has Grown at 53.71%

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.72 times

PRE-TAX PROFIT(Q)

Fallen at -67.03%

NET PROFIT(Q)

Fallen at -67.03%

Here's what is working for Shandong Boan Biotechnology Co., Ltd.

Net Sales
Highest at HKD 422.58 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (HKD MM)

Operating Profit
Highest at HKD 88.47 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (HKD MM)

Operating Profit Margin
Highest at 20.93 % and Grown
In each period in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Cash and Eqv
Highest at HKD 736.17 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -18.9% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shandong Boan Biotechnology Co., Ltd.

Interest
At HKD 20.98 MM has Grown at 53.71%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Pre-Tax Profit
Fallen at -67.03%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit
Fallen at -67.03%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)

Debtors Turnover Ratio
Lowest at 1.72 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio